ABT logo

ABT
Abbott Laboratories

17,237
Mkt Cap
$219.89B
Volume
6.7M
52W High
$141.23
52W Low
$110.86
PE Ratio
15.80
ABT Fundamentals
Price
$126.34
Prev Close
$127.95
Open
$128.24
50D MA
$132.13
Beta
0.40
Avg. Volume
5.44M
EPS (Annual)
$7.64
P/B
4.35
Rev/Employee
$367,982.46
Loading...
Loading...
News
all
press releases
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains
Abbott posts strong Q3 growth across key segments, but tariff pressures and weak Diagnostics weigh on near-term momentum.
Zacks·4d ago
News Placeholder
Company News for Oct 16, 2025
Companies In The News Are: HWC, PGR, ABT, ASML.
Zacks·8d ago
News Placeholder
NVST or ABT: Which Is the Better Value Stock Right Now?
NVST vs. ABT: Which Stock Is the Better Value Option?
Zacks·8d ago
News Placeholder
Pre-Markets in Green on Strong Q3 Bank Earnings
Pre-Markets in Green on Strong Q3 Bank Earnings.
Zacks·9d ago
News Placeholder
Pre-markets Strengthen on Solid Q3 Bank Earnings
We also see another better-than-expected manufacturing report out of New York State.
Zacks·9d ago
News Placeholder
Abbott's Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Climbs
ABT's Q3 earnings meet expectations as revenues climb 6.9% year over year, driven by double-digit gains in Medical Devices.
Zacks·9d ago
News Placeholder
Here's What Key Metrics Tell Us About Abbott (ABT) Q3 Earnings
Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·9d ago
News Placeholder
Abbott (ABT) Q3 Earnings Meet Estimates
Abbott (ABT) delivered earnings and revenue surprises of 0.00% and -0.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance
Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance PR Newswire ABBOTT PARK, Ill., Oct. 15, 2025...
PR Newswire·9d ago

Latest ABT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.